PlainPatent
USPTO 2015–2025 USPTO PatentsView US Corporation

2seventy Bio, Inc.

USPTO PatentsView assignee record - 21 granted patents across 9 technology areas, active 2022–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61K (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES).

Explore the portfolio See the ranking
21
Total patents granted
9
CPC technology areas
22.9
Avg claims per patent
-
5-year filing velocity

The verdict

2seventy holds 21 US patents across 9 technology areas, rank #13,816 of 50,000 tracked assignees.

#13,816
of 50,000 US assignees by volume
Top 7%
by Innovation Score (55.1/100)
22.9
avg claims per patent

Portfolio overview

2seventy bio, Inc. has been granted 21 US utility patents between 2022 and 2025, placing 2seventy bio, Inc. at rank #13,816 across all assignees tracked by PlainPatent. This portfolio spans 9 distinct Cooperative Patent Classification (CPC) subclasses, averaging 22.9 claims per patent with primary concentration in A61K (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES). As a US Corporation, 2seventy bio, Inc. is one of the more focused assignees in the PatentsView dataset. The composite Innovation Score of 55.1/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Historical data spans 2022 through 2025, with 21 total grants over that period. Velocity comparisons require five years of historical filings to calibrate. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. 2seventy bio, Inc.'s 22.9 average claims per patent reflects complex, broadly scoped inventions that are difficult for competitors to design around, while concentration in 9 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark 2seventy bio, Inc. against peers pursuing similar technology classes.

How does 2seventy compare?

Granted US patents 2015–2025 versus the largest corporate holders, this company marked ◀

patents

What this shows 2seventy holds 21 patents, placing it at rank #13,816 overall, well behind the volume leaders but ahead of the tens of thousands of smaller assignees in the dataset.

Source USPTO PatentsView, granted utility patents As of 2015–2025

2seventy's Innovation Score vs. every tracked assignee

Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)

55 Top 7% higher than 93% of 50,000 US assignees

0–10: 687 US assignees (1%). Below this entry. 10–20: 2,527 US assignees (5%). Below this entry. 20–30: 13,162 US assignees (26%). Below this entry. 30–40: 15,294 US assignees (31%). Below this entry. 40–50: 11,491 US assignees (23%). Below this entry. 50–60: 5,058 US assignees (10%). This entry sits in this band. 60–70: 1,537 US assignees (3%). Above this entry. 70–80: 234 US assignees (0%). Above this entry. 80–90: 10 US assignees (0%). Above this entry. 90–100: 0 US assignees (0%). Above this entry. This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2022–2025

02468 2022202320242025 2
USPTO utility patent grants by year · 2022–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2022–2019 baseline. Full figures in the table below.

View data table
2seventy bio, Inc. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2022 7 33.3%
2023 6 28.6%
2024 6 28.6%
2025 2 9.5%

Which technologies does 2seventy bio, Inc. patent most?

Top 9 of 9 technology areas

Patent Moat Analysis

Portfolio Volume Light
Tech Breadth Focused
Claim Depth Complex

Where it ranks

Overall rank by patents

#13,816

Across all tracked assignees

Innovation Score

55.1 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does 2seventy bio, Inc. hold?
2seventy bio, Inc. holds 21 US granted patents filed between 2022 and 2025, spanning 9 technology areas.
What is 2seventy bio, Inc.'s Innovation Score?
2seventy bio, Inc. has an Innovation Score of 55.1 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does 2seventy bio, Inc. focus on?
2seventy bio, Inc.'s top technology area is A61K (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES) with 20 patents. The company has filed patents in 9 CPC subclasses total.
Is 2seventy bio, Inc.'s patent filing rate increasing or decreasing?
Insufficient historical data is available to calculate a velocity trend for 2seventy bio, Inc..
What does claim depth mean for 2seventy bio, Inc.'s patents?
2seventy bio, Inc.'s patents average 22.9 claims each. This indicates complex, broadly scoped patents that are harder for competitors to design around.
How is the 2seventy bio, Inc. patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

Guides to patent portfolio analysis

How Innovation Score Works

Understand the four dimensions behind the composite score
How to Read Patent Data

Plain-English guide to CPC codes, claims, and metrics
Patent Moat Analysis

How companies use patents as competitive barriers

How to use this portfolio

2seventy's 21 grants land it in the top 7% by Innovation Score, but volume alone doesn't tell you where the strength sits.

  • Read that count against the largest US assignees before treating it as dominance - 2seventy ranks #13,816 of 50,000. Top 50 holders
  • Most of this portfolio concentrates in A61K - see who else leads that technology area. A61K leaders
  • Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works

Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.

Explore the patent dataset

A61K technology

2seventy bio, Inc.'s primary CPC class, all holders and yearly trends
Top 50 patent holders

See where 2seventy bio, Inc. ranks among the largest US patent assignees
All technology classes

Browse every CPC technology area by patent activity
How the score works

The four dimensions behind the Innovation Score

Related

All companies → | All technologies → | Rankings →
Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page
  • USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
  • Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
  • USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov